Latest / The AI in Business Podcast
Building Agile R&D Strategies Through Predictive Analytics - with Scott Bradley of Novartis
In this episode of the 'AI in Business' podcast, Scott Bradley, VP of AI and Innovation at Novartis, returns to discuss how AI is reshaping decision-making at the earliest stages of drug development—and what that means for the future of pharma investment strategy. Host Matthew DeMello and Scott explore how the pharmaceutical industry is transitioning from intuition-led portfolio choices to data-driven precision. They discuss the growing influence of AI in identifying viable drug candidates, designing complex proteins, and even solving long-standing manufacturing challenges. Scott also…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.